Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Uložené v:
| Vydané v: | Europace (London, England) Ročník 20; číslo 5; s. 731 - 732an |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
01.05.2018
|
| Predmet: | |
| ISSN: | 1099-5129, 1532-2092, 1532-2092 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Author | Tamargo, Juan L Agewall, Stefan Chen-Scarabelli, Carol Svendsen, Jesper Hastrup Sticherling, Christian Schilling, Richard van Gelder, Isabelle Dan, Gheorghe-Andrei Gorenek, Bulent Boriani, Giuseppe Lubinski, Andrzej Poulsen, Birgitte Klindt Ching, Keong Martinez, Felipe Potpara, Tatjana Lip, Gregory Y H Savelieva, Irina Pavlovic, Nikola Saba, Magdi Gaita, Fiorenzo Wolpert, Christian Sapp, John Lewis Martinez-Rubio, Antoni Ehrlich, Joachim R De Potter, Tom Kaski, Juan Carlos Piccini, Jonathan P Merkely, Bela Kjeldsen, Keld Okumura, Ken Borggrefe, Martin |
|---|---|
| Author_xml | – sequence: 1 givenname: Gheorghe-Andrei surname: Dan fullname: Dan, Gheorghe-Andrei organization: Colentina University Hospital, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania – sequence: 2 givenname: Antoni surname: Martinez-Rubio fullname: Martinez-Rubio, Antoni organization: University Hospital of Sabadell (University Autonoma of Barcelona), Plaça Cívica, Campus de la UAB, Barcelona, Spain – sequence: 3 givenname: Stefan surname: Agewall fullname: Agewall, Stefan organization: Oslo University Hospital Ullevål, Norway, Institute of Clinical Sciences, University of Oslo, Søsterhjemmet, Oslo, Norway – sequence: 4 givenname: Giuseppe surname: Boriani fullname: Boriani, Giuseppe organization: Policlinico di Modena, University of Modena and Reggio Emilia, Modena, Italy – sequence: 5 givenname: Martin surname: Borggrefe fullname: Borggrefe, Martin organization: Universitaetsmedizin Mannheim, Medizinische Klinik, Mannheim, Germany – sequence: 6 givenname: Fiorenzo surname: Gaita fullname: Gaita, Fiorenzo organization: Department of Medical Sciences, University of Turin, Citta' della Salute e della Scienza Hospital, Turin, Italy – sequence: 7 givenname: Isabelle surname: van Gelder fullname: van Gelder, Isabelle organization: Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands – sequence: 8 givenname: Bulent surname: Gorenek fullname: Gorenek, Bulent organization: Department of Cardiology, Eskisehir Osmangazi University, Büyükdere Mahallesi, Odunpazarı/Eskişehir, Turkey – sequence: 9 givenname: Juan Carlos surname: Kaski fullname: Kaski, Juan Carlos organization: Molecular and Clinical Sciences Research Institute, St. George’s, University of London, London, UK – sequence: 10 givenname: Keld surname: Kjeldsen fullname: Kjeldsen, Keld organization: Copenhagen University Hospital (Holbæk Hospital), Holbæk, Institute for Clinical Medicine, Copenhagen University, Copenhagen, Denmark, Department of Health Science and Technology, Aalborg University, Aalborg, Denmark – sequence: 11 givenname: Gregory Y H surname: Lip fullname: Lip, Gregory Y H organization: Institute of Cardiovascular Sciences, University of Birmingham, Centre For Cardiovascular Sciences, City Hospital, Birmingham, UK, Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark – sequence: 12 givenname: Bela surname: Merkely fullname: Merkely, Bela organization: Heart and Vascular Center, Semmelweis University, Budapest, Hungary – sequence: 13 givenname: Ken surname: Okumura fullname: Okumura, Ken organization: Saiseikai Akumamoto Hospital, Kumamoto, Japan – sequence: 14 givenname: Jonathan P surname: Piccini fullname: Piccini, Jonathan P organization: Department of Medicine, Duke Clinical Research Institute, Durham, USA – sequence: 15 givenname: Tatjana surname: Potpara fullname: Potpara, Tatjana organization: School of Medicine, Belgrade University; Cardiology Clinic, Clinical Centre of Serbia, Belgrade, Serbia – sequence: 16 givenname: Birgitte Klindt surname: Poulsen fullname: Poulsen, Birgitte Klindt organization: Aarhus University Hospital, Klinisk Farmakologisk Enhed, Aalborg, Denmark – sequence: 17 givenname: Magdi surname: Saba fullname: Saba, Magdi organization: Molecular and Clinical Sciences Research Institute, St. George’s, University of London, London, UK – sequence: 18 givenname: Irina surname: Savelieva fullname: Savelieva, Irina organization: Molecular and Clinical Sciences Research Institute, St. George’s, University of London, London, UK – sequence: 19 givenname: Juan L surname: Tamargo fullname: Tamargo, Juan L organization: Department of Pharmacology, School of Medicine, Universidad Complutense Madrid, Madrid, Spain – sequence: 20 givenname: Christian surname: Wolpert fullname: Wolpert, Christian organization: Department of Medicine - Cardiology, Klinikum Ludwigsburg, Ludwigsburg, Germany – sequence: 21 givenname: Christian surname: Sticherling fullname: Sticherling, Christian organization: Department of Cardiology, University Hospital Basel, Basel, Switzerland – sequence: 22 givenname: Joachim R surname: Ehrlich fullname: Ehrlich, Joachim R organization: Medizinische Klinik I-Kardiologie, Angiologie, Pneumologie, Wiesbaden, Germany – sequence: 23 givenname: Richard surname: Schilling fullname: Schilling, Richard organization: Barts Heart Centre, Trustee Arrhythmia Alliance and Atrial Fibrillation Association, London, UK – sequence: 24 givenname: Nikola surname: Pavlovic fullname: Pavlovic, Nikola organization: Department of Cardiology, University Hospital Centre Sestre milosrdnice, Croatia – sequence: 25 givenname: Tom surname: De Potter fullname: De Potter, Tom organization: Cardiology Department, Olv Aalst, Belgium – sequence: 26 givenname: Andrzej surname: Lubinski fullname: Lubinski, Andrzej organization: Uniwersytet Medyczny w Łodzi, Kierownik Kliniki Kardiologii Interwencyjnej, i Zaburzeń Rytmu Serca, Kierownik Katedry Chorób Wewnętrznych i Kardiologii, Uniwersytecki Szpital Kliniczny im WAM-Centralny Szpital Weteranów, Poland – sequence: 27 givenname: Jesper Hastrup surname: Svendsen fullname: Svendsen, Jesper Hastrup organization: Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark – sequence: 28 givenname: Keong surname: Ching fullname: Ching, Keong organization: Department of Cardiology, National Heart Centre Singapore, Singapore – sequence: 29 givenname: John Lewis surname: Sapp fullname: Sapp, John Lewis organization: QEII Health Sciences Center, Canada – sequence: 30 givenname: Carol surname: Chen-Scarabelli fullname: Chen-Scarabelli, Carol organization: Division of Cardiology, Richmond VA Medical Center, Richmond, USA – sequence: 31 givenname: Felipe surname: Martinez fullname: Martinez, Felipe organization: Instituto DAMIC/Fundacion Rusculleda, Universidad Nacional de Córdoba, Córdoba, Argentina |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29438514$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:138288029$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNp1ksuO0zAUhgMaxFxgzQ552UoTxs6lbdhVVZlWGomqBbGMTuyT1kxiZ2wHpjvegTfkSXDTiwQDKx_Z3_n_30fnMjhTWmEQvGH0HaNZfIOt0Q1w9MVjPIyfBxcsjaMwoll05muaZWHKouw8uLT2K6V0GGXpy-A8ypJ4lLLk4tnjWDkJxmy2blNLToRp1_bXj5-8kkpyqEhrkYAS5HQhkEsrtSI13Eu1fk-AcK0sKttaIjRva1SOlEbXxG2QTHcJERSZIRhHlp0RGVuruQS30-lNZ8txvzM5wSv_im5LdEkmYITUlV5vPbma9MkXbXbG5NbotiFeYE98A8vbCgxZbMDUwLuWa4JKaGNRkGLb5fkjxtGmN1uu-tc-lYRwAVyWfhL_BseLHdqFnSuHRnV_8GN5kvhJHu9uoPEa89Vk0X8VvCihsvj6cF4Fnz9MP01m4d3H2_lkfBfyJIlcKBDKIhlwRiFNiqJgnA8FSwHjmA8G8XDE2UgMy2KYUMqRRSUd0Xg0iAWlADEm8VUQ7nXtd2zaIm-MrMFscw0yP1zd-wrzJKMpG3i-t-cbox9atC6vpeVYVaBQtzaPKI0iltCUevTtAW2LGsVJ-rhdHkj3ADfaWoNlzqXrBuYMyCpnNN9tcX7c4ny_xb7v5q--o_T_On4DKB4BlQ |
| CitedBy_id | crossref_primary_10_1136_emermed_2021_211515 crossref_primary_10_1111_bcp_15030 crossref_primary_10_1016_j_mpaic_2021_03_009 crossref_primary_10_3389_fcvm_2021_664647 crossref_primary_10_3390_jcdd12040145 crossref_primary_10_3390_jcm9113729 crossref_primary_10_1093_eurheartj_suz228 crossref_primary_10_1016_j_bjae_2022_11_005 crossref_primary_10_1016_j_jaccao_2021_07_010 crossref_primary_10_1016_j_bjae_2022_11_001 crossref_primary_10_1177_1074248418810811 crossref_primary_10_3390_ijms241612859 crossref_primary_10_1016_j_asjsur_2025_03_005 crossref_primary_10_1080_17425255_2022_2046733 crossref_primary_10_1016_j_jddst_2022_103350 crossref_primary_10_1073_pnas_2025320118 crossref_primary_10_31083_RCM37301 crossref_primary_10_57264_cer_2022_0196 crossref_primary_10_1038_s41598_020_65190_y crossref_primary_10_1007_s40256_024_00693_x crossref_primary_10_1016_j_jacadv_2024_101117 crossref_primary_10_1016_j_hlc_2023_05_016 crossref_primary_10_1056_NEJMe2027180 crossref_primary_10_1097_MD_0000000000013599 crossref_primary_10_1136_bcr_2025_266174 crossref_primary_10_1111_jce_15339 crossref_primary_10_1007_s00228_022_03296_0 crossref_primary_10_3390_ijms24087515 crossref_primary_10_1007_s43440_020_00210_2 crossref_primary_10_1080_14796678_2025_2534323 crossref_primary_10_1186_s12913_019_4323_7 crossref_primary_10_1113_JP282357 crossref_primary_10_1016_j_phrs_2019_104444 crossref_primary_10_1093_eurheartj_ehaa612 crossref_primary_10_1136_openhrt_2020_001369 crossref_primary_10_1097_HCO_0000000000000966 crossref_primary_10_35336_VA_1436 crossref_primary_10_1007_s00399_024_01047_5 crossref_primary_10_3389_fcvm_2022_1002378 crossref_primary_10_1093_ehjqcco_qcac068 crossref_primary_10_2478_prolas_2021_0006 crossref_primary_10_35336_VA_1390 crossref_primary_10_1016_j_seizure_2019_07_002 crossref_primary_10_1097_FTD_0000000000000915 crossref_primary_10_1155_2020_6542028 crossref_primary_10_1371_journal_pmed_1003572 crossref_primary_10_3390_ph18071022 crossref_primary_10_1055_a_2679_6101 crossref_primary_10_1016_j_bbamem_2019_07_008 crossref_primary_10_1155_2020_5358467 crossref_primary_10_1016_j_arabjc_2021_103300 crossref_primary_10_1093_europace_euaf076 crossref_primary_10_1007_s00059_020_04960_w crossref_primary_10_1016_j_cjca_2018_08_018 crossref_primary_10_1161_JAHA_119_012511 crossref_primary_10_1007_s00424_022_02746_z crossref_primary_10_1007_s10557_020_07127_1 crossref_primary_10_1093_eurheartj_ehac270 crossref_primary_10_1016_j_autneu_2024_103223 crossref_primary_10_1016_j_mpaic_2024_02_001 crossref_primary_10_1038_s41598_025_14892_2 crossref_primary_10_1007_s00399_022_00919_y crossref_primary_10_1161_CIR_0000000000000909 crossref_primary_10_1016_j_ijoa_2024_104243 crossref_primary_10_1016_j_hrthm_2023_05_017 crossref_primary_10_1093_eurheartjsupp_suac022 crossref_primary_10_1016_j_yebeh_2019_05_038 crossref_primary_10_3389_fphys_2020_01068 crossref_primary_10_1016_j_tcm_2025_08_004 crossref_primary_10_1002_ejhf_3645 crossref_primary_10_1007_s41999_021_00504_5 crossref_primary_10_1038_s41598_025_85352_0 crossref_primary_10_1080_14779072_2022_2085686 crossref_primary_10_1093_ndt_gfac210 crossref_primary_10_3389_fbioe_2025_1538809 crossref_primary_10_1016_j_jacep_2022_03_014 crossref_primary_10_1016_j_ejphar_2020_173159 crossref_primary_10_1016_j_resuscitation_2022_08_008 crossref_primary_10_1007_s40256_022_00529_6 crossref_primary_10_1159_000528758 crossref_primary_10_1159_000529968 crossref_primary_10_18087_cardio_2022_6_n1667 crossref_primary_10_1007_s12181_020_00429_6 crossref_primary_10_1111_pace_14711 crossref_primary_10_1016_j_amjcard_2020_09_051 crossref_primary_10_1016_j_jacep_2021_01_014 crossref_primary_10_1093_ehjcvp_pvaa108 crossref_primary_10_1080_14779072_2020_1828064 crossref_primary_10_1016_j_phrs_2019_104521 crossref_primary_10_1007_s00246_021_02556_7 crossref_primary_10_3389_fcvm_2024_1386304 crossref_primary_10_1016_j_jacep_2024_08_003 crossref_primary_10_3390_jcdd10060238 crossref_primary_10_1007_s00204_018_2382_x crossref_primary_10_1080_07391102_2020_1851299 crossref_primary_10_1093_eurheartj_ehae176 crossref_primary_10_1016_j_molmed_2019_06_005 crossref_primary_10_2459_JCM_0000000000001182 crossref_primary_10_1007_s11936_021_00940_3 crossref_primary_10_1002_clc_24336 crossref_primary_10_3390_medsci13030102 crossref_primary_10_1136_bmjopen_2025_103090 crossref_primary_10_15829_1560_4071_2021_4482 |
| Cites_doi | 10.1161/CIRCULATIONAHA.109.192704 10.1093/europace/eul097 10.1161/01.CIR.81.6.1744 10.1111/pace.12426 10.1016/S0002-9149(00)00729-3 10.1056/NEJM199906173402402 10.1016/j.ahj.2004.04.031 10.1124/pr.110.003723 10.1161/CIRCULATIONAHA.106.618421 10.1001/archinte.165.3.258 10.1056/NEJM199906173402401 10.1056/NEJMoa041233 10.1016/j.ahj.2008.01.032 10.1016/S0002-9149(97)89119-9 10.1592/phco.22.1.66.33492 10.1016/S0002-9149(02)02867-9 10.1161/CIRCEP.115.003109 10.1177/107424840100600403 10.1378/chest.125.2.377 10.1093/eurheartj/ehp100 10.1161/01.CIR.80.6.1571 10.1136/heart.87.6.535 10.1016/j.amjcard.2004.05.038 10.1002/ejhf.64 10.1093/europace/euw295 10.1161/CIRCULATIONAHA.111.019927 10.1016/j.ahj.2007.08.033 10.1136/heart.84.3.251 10.1016/S0002-9149(97)89118-7 10.1016/S0140-6736(00)04196-9 10.1002/j.1552-4604.1984.tb01822.x 10.1016/0002-9149(92)91392-H 10.1016/0002-9149(89)90574-2 10.1001/jama.295.2.165 10.1016/j.hrthm.2008.10.036 10.1111/jce.12675 10.1056/NEJMoa041705 10.1016/S0002-9149(97)89120-5 10.1378/chest.121.4.1203 10.1016/j.cpcardiol.2007.05.002 10.1038/tpj.2012.14 10.1161/01.CIR.80.6.1557 10.1016/S0002-9149(99)00494-4 10.1093/europace/euv121 10.1016/j.jacc.2005.01.012 10.1016/S0002-9149(03)00671-4 10.1378/chest.10-2763 10.1001/jama.294.24.3093 10.1161/hc4801.099491 10.1161/01.CIR.100.4.369 10.1016/j.pharmthera.2008.06.001 10.1016/S0002-9149(98)00868-6 10.1016/0002-9149(93)90511-A 10.1136/hrt.2004.033811 10.1016/S0002-8703(96)90098-8 10.1016/S0140-6736(70)92639-5 10.1038/nrd705 10.1016/j.ccl.2015.07.007 10.1016/j.jacc.2012.01.067 10.1056/NEJMoa1602002 10.7326/0003-4819-126-8-199704150-00006 10.1016/j.amjcard.2004.08.041 10.1093/europace/eux274 10.1093/europace/euu194 10.1111/j.1365-2125.2007.02998.x 10.1093/europace/eur348 10.1056/NEJMoa1109867 10.1016/j.amjcard.2012.01.388 10.1161/CIRCRESAHA.110.230995 10.1161/CIRCEP.114.001759 10.1111/j.1540-8159.1986.tb05413.x 10.2165/11599950-000000000-00000 10.1016/S0733-8651(18)30650-7 10.1093/europace/euu208 10.1093/med/9780199557462.001.0001 10.1016/j.hrthm.2007.07.020 10.1093/europace/eul108 10.1161/CIRCEP.113.000805 10.1161/CIRCULATIONAHA.112.112300 10.1517/14656566.2015.1100170 10.1067/mem.2000.107655 10.1016/j.ijcard.2003.04.034 10.1161/CIRCEP.110.955393 10.1093/europace/eun130 10.1111/j.1399-6576.2005.00606.x 10.1016/S0002-9149(98)00223-9 10.1016/j.amjcard.2004.05.014 10.1007/978-1-4471-5475-4_6 10.1016/j.pharmthera.2011.08.002 10.1093/europace/eut272 10.1093/europace/euv309 10.2165/00003495-200262030-00001 10.2143/AC.59.3.2005179 10.1016/j.ahj.2013.05.015 10.1016/S0033-0620(99)70010-1 10.2143/AC.65.3.2050353 10.1016/j.ccep.2014.07.003 10.1093/europace/euw301 10.1016/S0735-1097(98)00609-3 10.1093/europace/euq450 10.1056/NEJMoa1001337 10.3122/jabfm.2011.01.080096 10.1016/S0002-8703(99)70401-1 10.1093/europace/euv202 10.1056/NEJMoa0800456 10.1016/j.ahj.2013.08.010 10.1111/j.1540-8167.2010.01764.x 10.1093/europace/eut160 10.1111/j.1540-8159.1998.tb01203.x 10.1016/j.amjcard.2014.11.005 10.1016/j.jacc.2015.05.018 10.1093/europace/eut274 10.1056/NEJMct065916 10.1016/j.ccep.2010.06.001 10.1016/S0002-8703(98)70031-6 10.2165/11591680-000000000-00000 10.1186/s40360-016-0053-1 10.1161/01.CIR.82.6.1932 10.1007/s00424-014-1665-1 10.1136/hrt.2009.187963 10.1007/BF00823592 10.1056/NEJMoa054686 10.1097/CCM.0000000000001257 10.1016/B978-1-4377-0285-9.00012-0 10.1016/B978-0-12-803376-0.00001-0 10.1093/europace/eut373 10.1111/j.1540-8159.2011.03208.x 10.1093/europace/euv233 10.1097/00001573-200001000-00002 10.1056/NEJMoa030207 10.1093/europace/euq382 10.1016/j.jacep.2015.04.016 10.1093/eurheartj/ehv320 10.1016/S0002-9149(03)00974-3 10.1007/s11739-014-1140-1 10.1093/eurheartj/ehs351 10.1093/europace/eum169 10.1111/j.1472-8206.2010.00848.x 10.1093/europace/eur416 10.1161/01.CIR.77.2.392 10.1097/FJC.0b013e3181bfaddc 10.1093/eurheartj/ehu284 10.1007/s11897-009-0003-y 10.1093/europace/eur002 10.1111/j.1540-8167.2000.tb00043.x 10.1056/NEJM197805252982101 10.1016/S0002-8703(98)70010-9 10.1016/S0002-9149(01)01806-9 10.1371/journal.pone.0080853 10.1001/archinte.1980.00330190048018 10.1093/oxfordjournals.eurheartj.a062498 10.1161/CIRCEP.115.002856 10.1016/j.ijcard.2012.10.050 10.1161/01.CIR.97.22.2237 10.1177/1074248410371947 10.1016/j.cjca.2010.11.001 10.1093/eurheartj/ehr218 10.2165/00003495-200464240-00003 10.1161/01.CIR.64.2.280 10.1016/0002-9149(91)90200-5 10.1016/S0002-9149(02)03378-7 10.1093/eurheartj/ehu354 10.1053/euhj.2000.2546 10.1016/j.amjcard.2007.04.020 10.1093/europace/eut063 10.1016/j.hrthm.2015.09.029 10.1016/j.hrthm.2015.05.036 10.1016/j.jacc.2003.08.013 10.1111/j.1540-8167.1998.tb00140.x 10.1016/j.resuscitation.2013.05.022 10.1093/europace/eut206 10.1111/j.1540-8159.1998.tb01202.x 10.1161/01.CIR.84.4.1831 10.1016/j.amjcard.2009.04.040 10.1111/j.1540-8167.2010.01737.x 10.1097/CCM.0b013e3181fd6ad7 10.1046/j.1460-9592.2002.01612.x 10.1093/europace/eul106 10.1093/eurheartj/ehs215 10.1016/j.hrthm.2010.03.036 10.1161/01.CIR.36.1.108 10.1161/CIRCULATIONAHA.108.839639 10.1097/FTD.0b013e318261c2c9 10.4330/wjc.v5.i6.175 10.1016/0002-8703(83)90007-8 10.1093/eurheartj/ehs104 10.1056/NEJM199103213241201 10.1016/j.ijcard.2013.04.047 10.1093/europace/eus305 10.1093/europace/eus009 10.1007/s40264-012-0012-8 10.1111/j.1540-8159.2007.00618.x 10.1016/j.ijcard.2007.11.006 10.1080/AC.67.4.2170681 10.1111/1755-5922.12052 10.1080/13543784.2017.1353601 10.2217/fca.12.78 10.1056/NEJMoa0803778 10.1093/europace/eur277 10.1161/CIRCRESAHA.114.302226 10.1016/j.ahj.2013.01.011 10.1161/CIRCULATIONAHA.109.874982 10.1016/S0140-6736(16)31258-2 10.1161/01.CIR.94.10.2535 10.1016/S0195-668X(03)00321-X 10.1016/S0002-9149(99)00275-1 10.7326/0003-4819-106-6-807 10.1161/01.CIR.99.17.2268 10.1093/europace/euq350 10.1016/j.jacc.2014.05.068 10.1016/S0140-6736(12)60570-4 10.1093/europace/eut293 10.1093/europace/eum181 10.1093/europace/eur023 10.1093/europace/euv112 10.1016/S0735-1097(97)00534-2 10.1016/S0002-9149(98)00078-2 10.2146/ajhp110270 10.1016/j.amjcard.2015.09.042 10.1056/NEJM199712183372501 10.1056/NEJM198908103210629 10.1093/europace/eus380 10.1016/j.ehj.2003.10.020 10.1016/j.jacc.2015.08.038 10.1517/17425255.2012.685157 10.1016/j.athoracsur.2006.06.032 10.1161/CIR.0000000000000040 10.1161/CIRCEP.109.870204 10.1016/j.ahj.2005.09.009 10.1016/j.amjmed.2015.08.039 10.1097/MJT.0b013e3181f94c38 10.1016/S0735-1097(02)02705-5 10.1161/01.CIR.89.1.206 10.1161/CIRCEP.114.001517 |
| ContentType | Journal Article |
| Contributor | Pavlovic, Nikola Ehrlich, Joachim R Lubinski, Andrzej Sapp, John Lewis Chen-Scarabelli, Carol De Potter, Tom Ching, Keong Svendsen, Jesper Hastrup Martinez, Felipe Sticherling, Christian Schilling, Richard |
| Contributor_xml | – sequence: 1 givenname: Christian surname: Sticherling fullname: Sticherling, Christian – sequence: 2 givenname: Joachim R surname: Ehrlich fullname: Ehrlich, Joachim R – sequence: 3 givenname: Richard surname: Schilling fullname: Schilling, Richard – sequence: 4 givenname: Nikola surname: Pavlovic fullname: Pavlovic, Nikola – sequence: 5 givenname: Tom surname: De Potter fullname: De Potter, Tom – sequence: 6 givenname: Andrzej surname: Lubinski fullname: Lubinski, Andrzej – sequence: 7 givenname: Jesper Hastrup surname: Svendsen fullname: Svendsen, Jesper Hastrup – sequence: 8 givenname: Keong surname: Ching fullname: Ching, Keong – sequence: 9 givenname: John Lewis surname: Sapp fullname: Sapp, John Lewis – sequence: 10 givenname: Carol surname: Chen-Scarabelli fullname: Chen-Scarabelli, Carol – sequence: 11 givenname: Felipe surname: Martinez fullname: Martinez, Felipe |
| CorporateAuthor | ESC Scientific Document Group |
| CorporateAuthor_xml | – name: ESC Scientific Document Group |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ADTPV AOWAS |
| DOI | 10.1093/europace/eux373 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic SwePub SwePub Articles |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-2092 |
| EndPage | 732an |
| ExternalDocumentID | oai_swepub_ki_se_490516 29438514 10_1093_europace_eux373 |
| Genre | Systematic Review Journal Article |
| GroupedDBID | --- .2P .I3 .XZ .ZR 0R~ 29G 2WC 4.4 48X 53G 5GY 5VS 5WA 6PF 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AAUAY AAUQX AAVAP AAWTL AAYXX ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABPQP ABPTD ABQLI ABVGC ABWST ABXVV ABZBJ ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADOCK ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AMNDL APIBT APWMN AXUDD BAWUL BAYMD BEYMZ BHONS BTRTY BVRKM CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KBUDW KOP KQ8 KSI KSN M-Z MHKGH N9A NGC NOMLY NOYVH O9- OAUYM OAWHX ODMLO OJQWA OK1 OPAEJ OVD P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 ROL ROX RPM RUSNO RW1 RXO SEL SV3 TCURE TEORI TJX TOX TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 CGR CUY CVF ECM EIF NPM OJZSN 7X8 --K 1B1 1TH ADTPV AOWAS C1A CAG COF IHE M41 NQ- NTWIH NU- O0~ RPZ UHS |
| ID | FETCH-LOGICAL-c442t-deafb46c10a54bbb1cc7d15ae33c66378c18d7fb7400ce12f0803863d00aa3e43 |
| ISICitedReferencesCount | 143 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000432254000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1099-5129 1532-2092 |
| IngestDate | Tue Nov 25 03:28:48 EST 2025 Fri Jul 11 12:26:05 EDT 2025 Mon Jul 21 06:05:42 EDT 2025 Tue Nov 18 22:27:18 EST 2025 Sat Nov 29 05:18:49 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| License | https://academic.oup.com/journals/pages/about_us/legal/notices |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c442t-deafb46c10a54bbb1cc7d15ae33c66378c18d7fb7400ce12f0803863d00aa3e43 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://academic.oup.com/europace/article-pdf/20/5/731/24794585/eux373.pdf |
| PMID | 29438514 |
| PQID | 2002214050 |
| PQPubID | 23479 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_490516 proquest_miscellaneous_2002214050 pubmed_primary_29438514 crossref_citationtrail_10_1093_europace_eux373 crossref_primary_10_1093_europace_eux373 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-05-01 |
| PublicationDateYYYYMMDD | 2018-05-01 |
| PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Europace (London, England) |
| PublicationTitleAlternate | Europace |
| PublicationYear | 2018 |
| References | Gopinathannair ( key 20180507100040_eux373-B110) 2015; 66 Galperín ( key 20180507100040_eux373-B146) 2001; 6 Delannoy ( key 20180507100040_eux373-B227) 2013; 15 Chimienti ( key 20180507100040_eux373-B155) 1996; 77 Snider ( key 20180507100040_eux373-B10) 2012; 69 Reiffel ( key 20180507100040_eux373-B88) 2000; 15 Page ( key 20180507100040_eux373-B116) 2016; 133 Darkner ( key 20180507100040_eux373-B187) 2014; 35 Boriani ( key 20180507100040_eux373-B89) 1997; 126 Mooss ( key 20180507100040_eux373-B76) 2004; 148 Brembilla-Perrot ( key 20180507100040_eux373-B140) 2013; 168 Sherrid ( key 20180507100040_eux373-B176) 2005; 45 ( key 20180507100040_eux373-B13) 1994 Hudzik ( key 20180507100040_eux373-B254) 2014; 9 Shah ( key 20180507100040_eux373-B64) 2012; 109 The Sicilian gambit ( key 20180507100040_eux373-B14) 1991; 84 Kowey ( key 20180507100040_eux373-B82) 2004; 94 Tschuppert ( key 20180507100040_eux373-B165) 2007; 64 Ramirez ( key 20180507100040_eux373-B102) 2013; 13 Kirchhof ( key 20180507100040_eux373-B158) 2012; 380 de Paola ( key 20180507100040_eux373-B174) 1999; 84 Pacifico ( key 20180507100040_eux373-B230) 1999; 340 Juul-Möller ( key 20180507100040_eux373-B170) 1990; 82 Karlson ( key 20180507100040_eux373-B179) 1988; 9 Dasgupta ( key 20180507100040_eux373-B36) 2012; 34 Schleifer ( key 20180507100040_eux373-B195) 2015; 16 Kalusche ( key 20180507100040_eux373-B172) 1994; 83 Suppl 5 Singh ( key 20180507100040_eux373-B138) 2005; 352 Zimetbaum ( key 20180507100040_eux373-B180) 2007; 356 Van Gelder ( key 20180507100040_eux373-B152) 1989; 64 Manu ( key 20180507100040_eux373-B201) 2016 Priori ( key 20180507100040_eux373-B219) 2013; 15 Alboni ( key 20180507100040_eux373-B93) 2010; 96 Gillis ( key 20180507100040_eux373-B127) 2011; 27 Helfant ( key 20180507100040_eux373-B251) 1967; 36 Kawabata ( key 20180507100040_eux373-B243) 2015; 7 Frommeyer ( key 20180507100040_eux373-B33) 2015; 13 Calkins ( key 20180507100040_eux373-B240) 2018; 20 Hilleman ( key 20180507100040_eux373-B122) 2002; 22 Binici ( key 20180507100040_eux373-B111) 2010; 121 Freemantle ( key 20180507100040_eux373-B182) 2011; 13 Heidbuchel ( key 20180507100040_eux373-B32) 2015; 17 Nada ( key 20180507100040_eux373-B34) 2013; 165 Pinski ( key 20180507100040_eux373-B248) 2002; 25 Kochiadakis ( key 20180507100040_eux373-B163) 2004; 94 Dogan ( key 20180507100040_eux373-B164) 2004; 59 Konstantopoulou ( key 20180507100040_eux373-B242) 2013; 5 Kowey ( key 20180507100040_eux373-B79) 2009; 2 Bunch ( key 20180507100040_eux373-B214) 2011; 34 Narayanan ( key 20180507100040_eux373-B245) 2015; 17 Deneer ( key 20180507100040_eux373-B35) 2011; 28 Roden ( key 20180507100040_eux373-B95) 2011; 109 Viskin ( key 20180507100040_eux373-B220) 2007; 9 Dagres ( key 20180507100040_eux373-B185) 2013; 15 Dan ( key 20180507100040_eux373-B5) 2014 Benditt ( key 20180507100040_eux373-B173) 1999; 84 Conen ( key 20180507100040_eux373-B114) 2012; 126 Wolbrette ( key 20180507100040_eux373-B49) 2003; 91 Lip ( key 20180507100040_eux373-B54) 2011; 139 Arsenault ( key 20180507100040_eux373-B71) 2013; 1 Singh ( key 20180507100040_eux373-B147) 2003; 92 Van Gelder ( key 20180507100040_eux373-B191) 2016; 388 Domanski ( key 20180507100040_eux373-B216) 1999; 33 Bagshaw ( key 20180507100040_eux373-B75) 2006; 82 Allen LaPointe ( key 20180507100040_eux373-B2) 2013; 166 Gulizia ( key 20180507100040_eux373-B150) 2008; 155 Singh ( key 20180507100040_eux373-B171) 1991; 68 Katritsis ( key 20180507100040_eux373-B115) 2017; 19 Kiper ( key 20180507100040_eux373-B23) 2015; 467 Larsen ( key 20180507100040_eux373-B112) 2015; 66 ( key 20180507100040_eux373-B60) 2005; 45 Chung ( key 20180507100040_eux373-B56) 2014; 37 Oral ( key 20180507100040_eux373-B137) 1999; 340 DiSegni ( key 20180507100040_eux373-B247) 1980; 140 Antman ( key 20180507100040_eux373-B252) 1990; 81 Elliott ( key 20180507100040_eux373-B58) 2014; 35 Skroubis ( key 20180507100040_eux373-B85) 2005; 49 Pitt ( key 20180507100040_eux373-B217) 2003; 348 Woosley ( key 20180507100040_eux373-B100) 1978; 298 Wynn ( key 20180507100040_eux373-B186) 2014; 7 McMurray ( key 20180507100040_eux373-B192) 2012; 33 Behr ( key 20180507100040_eux373-B98) 2013; 34 Pedersen ( key 20180507100040_eux373-B51) 2014; 16 Voora ( key 20180507100040_eux373-B96) 2012; 60 VanderLugt ( key 20180507100040_eux373-B81) 1999; 100 Baman ( key 20180507100040_eux373-B107) 2010; 7 Kristensen ( key 20180507100040_eux373-B83) 2014; 35 Lane ( key 20180507100040_eux373-B11) 2015; 17 Driver ( key 20180507100040_eux373-B66) 2015; 26 Nair ( key 20180507100040_eux373-B141); 24 Aliot ( key 20180507100040_eux373-B154) 1996; 77 Saborido ( key 20180507100040_eux373-B134) 2010; 14 Camm ( key 20180507100040_eux373-B188) 2010; 12 Le Heuzey ( key 20180507100040_eux373-B169) 2010; 21 Verrier ( key 20180507100040_eux373-B215) 2013; 15 Rosen ( key 20180507100040_eux373-B16) 2010; 55 Lip ( key 20180507100040_eux373-B131) 2014; 16 Chevalier ( key 20180507100040_eux373-B120) 2003; 41 Indik ( key 20180507100040_eux373-B28) 2010; 2 Carunchio ( key 20180507100040_eux373-B153) 1995; 25 Myerburg ( key 20180507100040_eux373-B250) 1989; 80 Meinertz ( key 20180507100040_eux373-B162) 2002; 90 Goldenberg ( key 20180507100040_eux373-B223) 2010; 21 Jacob ( key 20180507100040_eux373-B213) 2012; 19 Savelieva ( key 20180507100040_eux373-B80) 2014; 16 Adams ( key 20180507100040_eux373-B37) 2014; 16 Kirchhof ( key 20180507100040_eux373-B8) 2016; 18 Piccini ( key 20180507100040_eux373-B208) 2009; 30 Kumar ( key 20180507100040_eux373-B57) 2015; 33 Fuster ( key 20180507100040_eux373-B193) 2006; 8 Ramires ( key 20180507100040_eux373-B218) 2000; 85 Zaza ( key 20180507100040_eux373-B24) 2008; 119 Aliot ( key 20180507100040_eux373-B39) 2011; 13 Anderson ( key 20180507100040_eux373-B151) 1989; 80 Køber ( key 20180507100040_eux373-B167) 2008; 358 Chatterjee ( key 20180507100040_eux373-B206) 2013; 168 Schwartz ( key 20180507100040_eux373-B84) 1983; 106 Kochiadakis ( key 20180507100040_eux373-B144) 1998; 81 Chorin ( key 20180507100040_eux373-B224) 2017 Roden ( key 20180507100040_eux373-B97) 2002; 1 Brunton ( key 20180507100040_eux373-B27) 2011 Daoud ( key 20180507100040_eux373-B72) 1997; 337 Boriani ( key 20180507100040_eux373-B91) 1998; 21 Richiardi ( key 20180507100040_eux373-B159) 1992; 37 Aronow ( key 20180507100040_eux373-B50) 2013 Allen LaPointe ( key 20180507100040_eux373-B1) 2015; 115 Locati ( key 20180507100040_eux373-B48) 1998; 97 Steg ( key 20180507100040_eux373-B207) 2012; 33 Capucci ( key 20180507100040_eux373-B118) 1992; 70 ( key 20180507100040_eux373-B15) 2001; 104 Kirchhof ( key 20180507100040_eux373-B129) 2013; 166 Belhassen ( key 20180507100040_eux373-B221) 2015; 8 Govindan ( key 20180507100040_eux373-B4) 2010; 15 Simantirakis ( key 20180507100040_eux373-B105) 2012; 14 Van Gelder ( key 20180507100040_eux373-B189) 2010; 362 Boriani ( key 20180507100040_eux373-B194) 1996; 131 Connolly ( key 20180507100040_eux373-B52) 2006; 295 Boriani ( key 20180507100040_eux373-B59) 2015; 17 Ling ( key 20180507100040_eux373-B104) 2014; 7 Tzivoni ( key 20180507100040_eux373-B246) 1988; 77 Reisinger ( key 20180507100040_eux373-B125) 1998; 81 Boriani ( key 20180507100040_eux373-B92) 2004; 64 Touboul ( key 20180507100040_eux373-B168) 2003; 24 Roffi ( key 20180507100040_eux373-B212) 2015; 37 Giri ( key 20180507100040_eux373-B73) 2001; 357 Echt ( key 20180507100040_eux373-B109) 1991; 324 Lehmann ( key 20180507100040_eux373-B44) 1996; 94 Wiśniowska ( key 20180507100040_eux373-B244) 2016; 17 Zipes ( key 20180507100040_eux373-B203) 2006; 8 Camm ( key 20180507100040_eux373-B130) 2012; 14 Naccarelli ( key 20180507100040_eux373-B156) 1996; 77 Pisters ( key 20180507100040_eux373-B183) 2014; 16 Heijman ( key 20180507100040_eux373-B26) 2014; 114 Wurdeman ( key 20180507100040_eux373-B77) 2002; 121 Pelosi ( key 20180507100040_eux373-B233) 2000; 11 Pedersen ( key 20180507100040_eux373-B43) 2007; 100 Tamargo ( key 20180507100040_eux373-B38) 2012; 35 Piccini ( key 20180507100040_eux373-B211) 2011; 39 Burashnikov ( key 20180507100040_eux373-B20) 2011; 132 Leong-Sit ( key 20180507100040_eux373-B237) 2011; 4 Turgeon ( key 20180507100040_eux373-B6) 2012 Blomström-Lundqvist ( key 20180507100040_eux373-B117) 2003; 42 Preston ( key 20180507100040_eux373-B31) 2016 Drew ( key 20180507100040_eux373-B200) 2010; 121 Chan ( key 20180507100040_eux373-B99) 2012; 8 Kroll ( key 20180507100040_eux373-B231) 2010; 24 Leenhardt ( key 20180507100040_eux373-B198) 1994; 89 Kochiadakis ( key 20180507100040_eux373-B145) 2000; 84 Hohnloser ( key 20180507100040_eux373-B232) 2006; 114 Myerburg ( key 20180507100040_eux373-B30) 1981; 64 Turco ( key 20180507100040_eux373-B234) 2007; 30 Gu ( key 20180507100040_eux373-B235) 2012; 67 Roffi ( key 20180507100040_eux373-B197) 2016; 37 Van Gelder ( key 20180507100040_eux373-B190) 2006; 8 Boutitie ( key 20180507100040_eux373-B209) 1999; 99 Arrigo ( key 20180507100040_eux373-B69) 2015; 43 Gowda ( key 20180507100040_eux373-B45) 2004; 95 Lehmann ( key 20180507100040_eux373-B46) 1999; 83 van der Werf ( key 20180507100040_eux373-B225) 2012; 14 Winkelmann ( key 20180507100040_eux373-B249) 1987; 106 Huang ( key 20180507100040_eux373-B228) 1986; 9 Boriani ( key 20180507100040_eux373-B119) 1998; 21 Gorenek ( key 20180507100040_eux373-B202) 2014; 16 Roden ( key 20180507100040_eux373-B241) 2014; 6 Turakhia ( key 20180507100040_eux373-B9) 2007; 32 Pritchett ( key 20180507100040_eux373-B42) 2003; 92 Kudenchuk ( key 201 29722802 - Europace. 2018 May 1;20(5):738 |
| References_xml | – volume: 121 start-page: 1047 year: 2010 ident: key 20180507100040_eux373-B200 article-title: Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192704 – volume: 8 start-page: 651 year: 2006 ident: key 20180507100040_eux373-B193 article-title: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation publication-title: Europace doi: 10.1093/europace/eul097 – volume: 81 start-page: 1744 year: 1990 ident: key 20180507100040_eux373-B252 article-title: Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study publication-title: Circulation doi: 10.1161/01.CIR.81.6.1744 – volume: 37 start-page: 1338 year: 2014 ident: key 20180507100040_eux373-B56 article-title: Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality publication-title: Pacing Clin Electrophysiol doi: 10.1111/pace.12426 – volume: 85 start-page: 1207 year: 2000 ident: key 20180507100040_eux373-B218 article-title: Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy publication-title: Am J Cardiol doi: 10.1016/S0002-9149(00)00729-3 – volume: 340 start-page: 1855 year: 1999 ident: key 20180507100040_eux373-B230 article-title: Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group publication-title: N Engl J Med doi: 10.1056/NEJM199906173402402 – volume: 148 start-page: 641 year: 2004 ident: key 20180507100040_eux373-B76 article-title: Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial publication-title: Am Heart J doi: 10.1016/j.ahj.2004.04.031 – volume: 62 start-page: 760 year: 2010 ident: key 20180507100040_eux373-B101 article-title: Drug-induced long QT syndrome publication-title: Pharmacol Rev doi: 10.1124/pr.110.003723 – volume: 114 start-page: 104 year: 2006 ident: key 20180507100040_eux373-B232 article-title: Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.618421 – volume: 165 start-page: 258 year: 2005 ident: key 20180507100040_eux373-B128 article-title: Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis publication-title: Arch Intern Med doi: 10.1001/archinte.165.3.258 – volume: 340 start-page: 1849 year: 1999 ident: key 20180507100040_eux373-B137 article-title: Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment publication-title: N Engl J Med doi: 10.1056/NEJM199906173402401 – volume: 351 start-page: 2384 year: 2004 ident: key 20180507100040_eux373-B94 article-title: Outpatient treatment of recent-onset atrial fibrillation with the ‘pill-in-the-pocket’ approach publication-title: N Engl J Med doi: 10.1056/NEJMoa041233 – volume: 156 start-page: 373.e1 year: 2008 ident: key 20180507100040_eux373-B175 article-title: The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker publication-title: Am Heart J doi: 10.1016/j.ahj.2008.01.032 – volume: 77 start-page: 60A year: 1996 ident: key 20180507100040_eux373-B155 article-title: Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)89119-9 – volume: 22 start-page: 66 year: 2002 ident: key 20180507100040_eux373-B122 article-title: Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials publication-title: Pharmacotherapy doi: 10.1592/phco.22.1.66.33492 – volume: 90 start-page: 1300 year: 2002 ident: key 20180507100040_eux373-B162 article-title: Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study) publication-title: Am J Cardiol doi: 10.1016/S0002-9149(02)02867-9 – volume: 8 start-page: 1393 year: 2015 ident: key 20180507100040_eux373-B221 article-title: Management of Brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.115.003109 – volume: 6 start-page: 341 year: 2001 ident: key 20180507100040_eux373-B146 article-title: Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial publication-title: J Cardiovasc Pharmacol Ther doi: 10.1177/107424840100600403 – volume: 125 start-page: 377 year: 2004 ident: key 20180507100040_eux373-B148 article-title: Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses publication-title: Chest doi: 10.1378/chest.125.2.377 – volume: 30 start-page: 1245 year: 2009 ident: key 20180507100040_eux373-B208 article-title: Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials publication-title: Eur Heart J doi: 10.1093/eurheartj/ehp100 – volume: 80 start-page: 1571 year: 1989 ident: key 20180507100040_eux373-B250 article-title: Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol publication-title: Circulation doi: 10.1161/01.CIR.80.6.1571 – volume: 87 start-page: 535 year: 2002 ident: key 20180507100040_eux373-B121 article-title: Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation publication-title: Heart doi: 10.1136/heart.87.6.535 – volume: 94 start-page: 663 year: 2004 ident: key 20180507100040_eux373-B82 article-title: Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.05.038 – volume: 83 Suppl 5 start-page: 109 year: 1994 ident: key 20180507100040_eux373-B172 article-title: Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation—conversion and 12-month follow-up—a randomized comparison publication-title: Zeitschrift Für Kardiol – volume: 16 start-page: 483 year: 2014 ident: key 20180507100040_eux373-B37 article-title: A perspective on re-evaluating digoxin’s role in the current management of patients with chronic systolic heart failure: Targeting serum concentration to reduce hospitalization and improve safety profile publication-title: Eur J Heart Fail doi: 10.1002/ejhf.64 – volume: 18 start-page: 1609 year: 2016 ident: key 20180507100040_eux373-B8 article-title: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS publication-title: Europace doi: 10.1093/europace/euw295 – volume: 125 start-page: 381 year: 2012 ident: key 20180507100040_eux373-B143 article-title: Antiarrhythmic drug therapy for atrial fibrillation publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.019927 – volume: 155 start-page: 100 year: 2008 ident: key 20180507100040_eux373-B150 article-title: A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) publication-title: Am Heart J doi: 10.1016/j.ahj.2007.08.033 – volume: 84 start-page: 251 year: 2000 ident: key 20180507100040_eux373-B145 article-title: Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study publication-title: Heart doi: 10.1136/heart.84.3.251 – volume: 77 start-page: 53A year: 1996 ident: key 20180507100040_eux373-B156 article-title: Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)89118-7 – volume: 357 start-page: 830 year: 2001 ident: key 20180507100040_eux373-B73 article-title: Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial publication-title: Lancet (Lond, Engl) doi: 10.1016/S0140-6736(00)04196-9 – volume: 24 start-page: 129 year: 1984 ident: key 20180507100040_eux373-B12 article-title: A classification of antiarrhythmic actions reassessed after a decade of new drugs publication-title: J Clin Pharmacol doi: 10.1002/j.1552-4604.1984.tb01822.x – volume: 70 start-page: 69 year: 1992 ident: key 20180507100040_eux373-B118 article-title: Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension publication-title: Am J Cardiol doi: 10.1016/0002-9149(92)91392-H – volume: 64 start-page: 1317 year: 1989 ident: key 20180507100040_eux373-B152 article-title: Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter publication-title: Am J Cardiol doi: 10.1016/0002-9149(89)90574-2 – volume: 295 start-page: 165 year: 2006 ident: key 20180507100040_eux373-B52 article-title: Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial publication-title: JAMA doi: 10.1001/jama.295.2.165 – volume: 6 start-page: 152 year: 2009 ident: key 20180507100040_eux373-B136 article-title: Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2008.10.036 – volume: 26 start-page: 698 year: 2015 ident: key 20180507100040_eux373-B66 article-title: Catheter ablation of arrhythmia during pregnancy publication-title: J Cardiovasc Electrophysiol doi: 10.1111/jce.12675 – volume: 352 start-page: 1861 year: 2005 ident: key 20180507100040_eux373-B138 article-title: Amiodarone versus sotalol for atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa041705 – volume: 77 start-page: 66A year: 1996 ident: key 20180507100040_eux373-B154 article-title: Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group publication-title: Am J Cardiol doi: 10.1016/S0002-9149(97)89120-5 – volume: 35 start-page: :2383–2431 year: 2014 ident: key 20180507100040_eux373-B83 article-title: 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology publication-title: Eur Heart J – volume: 121 start-page: 1203 year: 2002 ident: key 20180507100040_eux373-B77 article-title: Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis publication-title: Chest doi: 10.1378/chest.121.4.1203 – volume: 32 start-page: 501 year: 2007 ident: key 20180507100040_eux373-B9 article-title: Sudden cardiac death: epidemiology, mechanisms, and therapy publication-title: Curr Probl Cardiol doi: 10.1016/j.cpcardiol.2007.05.002 – volume: 13 start-page: 325 year: 2013 ident: key 20180507100040_eux373-B102 article-title: Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointes publication-title: Pharmacogenomics J doi: 10.1038/tpj.2012.14 – volume: 80 start-page: 1557 year: 1989 ident: key 20180507100040_eux373-B151 article-title: Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group publication-title: Circulation doi: 10.1161/01.CIR.80.6.1557 – volume: 84 start-page: 1033 year: 1999 ident: key 20180507100040_eux373-B174 article-title: Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators. The Cardiology Society of São Paulo publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)00494-4 – volume: 17 start-page: ii7 year: 2015 ident: key 20180507100040_eux373-B245 article-title: The 12-lead electrocardiogram and risk of sudden death: current utility and future prospects publication-title: Europace doi: 10.1093/europace/euv121 – volume: 45 start-page: 1251 year: 2005 ident: key 20180507100040_eux373-B176 article-title: Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2005.01.012 – volume: 92 start-page: 468 year: 2003 ident: key 20180507100040_eux373-B147 article-title: Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]) publication-title: Am J Cardiol doi: 10.1016/S0002-9149(03)00671-4 – volume: 139 start-page: 738 year: 2011 ident: key 20180507100040_eux373-B54 article-title: The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution? publication-title: Chest doi: 10.1378/chest.10-2763 – volume: 294 start-page: 3093 year: 2005 ident: key 20180507100040_eux373-B74 article-title: Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.294.24.3093 – volume: 104 start-page: 2865 year: 2001 ident: key 20180507100040_eux373-B15 article-title: New approaches to antiarrhythmic therapy, Part I: emerging therapeutic applications of the cell biology of cardiac arrhythmias publication-title: Circulation doi: 10.1161/hc4801.099491 – volume: 100 start-page: 369 year: 1999 ident: key 20180507100040_eux373-B81 article-title: Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery publication-title: Circulation doi: 10.1161/01.CIR.100.4.369 – volume: 119 start-page: 326 year: 2008 ident: key 20180507100040_eux373-B24 article-title: Pathophysiology and pharmacology of the cardiac late sodium current publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2008.06.001 – volume: 83 start-page: 354 year: 1999 ident: key 20180507100040_eux373-B46 article-title: JTc prolongation with d,l-sotalol in women versus men publication-title: Am J Cardiol doi: 10.1016/S0002-9149(98)00868-6 – volume: 71 start-page: 558 year: 1993 ident: key 20180507100040_eux373-B160 article-title: Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/0002-9149(93)90511-A – volume: 91 start-page: 618 year: 2005 ident: key 20180507100040_eux373-B78 article-title: Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis publication-title: Heart doi: 10.1136/hrt.2004.033811 – volume: 131 start-page: 1214 year: 1996 ident: key 20180507100040_eux373-B194 article-title: Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation publication-title: Am Heart J doi: 10.1016/S0002-8703(96)90098-8 – volume: 296 start-page: 67 year: 1970 ident: key 20180507100040_eux373-B229 article-title: Influence of beta-blockade on myocardial threshold in patients with pacemakers publication-title: Lancet (Lond, Engl) doi: 10.1016/S0140-6736(70)92639-5 – volume: 1 start-page: 37 year: 2002 ident: key 20180507100040_eux373-B97 article-title: The genetic basis of variability in drug responses publication-title: Nat Rev Drug Discov doi: 10.1038/nrd705 – volume: 33 start-page: 571 year: 2015 ident: key 20180507100040_eux373-B57 article-title: Arrhythmias in adult congenital heart disease. Diagnosis and management publication-title: Cardiol Clin doi: 10.1016/j.ccl.2015.07.007 – volume: 60 start-page: 9 year: 2012 ident: key 20180507100040_eux373-B96 article-title: Clinical application of cardiovascular pharmacogenetics publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2012.01.067 – volume: 374 start-page: 1911 year: 2016 ident: key 20180507100040_eux373-B68 article-title: Rate control versus rhythm control for atrial fibrillation after cardiac surgery publication-title: N Engl J Med doi: 10.1056/NEJMoa1602002 – volume: 126 start-page: 621 year: 1997 ident: key 20180507100040_eux373-B89 article-title: Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial publication-title: Ann Intern Med doi: 10.7326/0003-4819-126-8-199704150-00006 – volume: 94 start-page: 1563 year: 2004 ident: key 20180507100040_eux373-B163 article-title: Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.08.041 – volume: 20 start-page: e1 year: 2018 ident: key 20180507100040_eux373-B240 article-title: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation publication-title: Europace doi: 10.1093/europace/eux274 – volume: 16 start-page: 1257 year: 2014 ident: key 20180507100040_eux373-B51 article-title: EHRA/HRS/APHRS expert consensus on ventricular arrhythmias publication-title: Europace doi: 10.1093/europace/euu194 – volume: 64 start-page: 785 year: 2007 ident: key 20180507100040_eux373-B165 article-title: Effect of dronedarone on renal function in healthy subjects publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2007.02998.x – volume: 17 start-page: 1601 year: 2015 ident: key 20180507100040_eux373-B7 article-title: 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death publication-title: Europace – volume: 14 start-page: 466 year: 2012 ident: key 20180507100040_eux373-B105 article-title: Arrhythmia-induced cardiomyopathies: the riddle of the chicken and the egg still unanswered? publication-title: Europace doi: 10.1093/europace/eur348 – volume: 365 start-page: 2268 year: 2011 ident: key 20180507100040_eux373-B184 article-title: Dronedarone in high-risk permanent atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1109867 – volume: 109 start-page: 1614 year: 2012 ident: key 20180507100040_eux373-B64 article-title: Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2012.01.388 – volume: 109 start-page: 807 year: 2011 ident: key 20180507100040_eux373-B95 article-title: Cardiovascular pharmacogenomics publication-title: Circ Res doi: 10.1161/CIRCRESAHA.110.230995 – volume: 65 start-page: 367 year: 1984 ident: key 20180507100040_eux373-B178 article-title: The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo publication-title: S Afr Med J – volume: 7 start-page: 841 year: 2014 ident: key 20180507100040_eux373-B186 article-title: Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.114.001759 – volume: 9 start-page: 660 year: 1986 ident: key 20180507100040_eux373-B228 article-title: Effects of antiarrhythmic drugs on the chronic pacing threshold and the endocardial R wave amplitude in the conscious dog publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.1986.tb05413.x – volume: 35 start-page: 273 year: 2012 ident: key 20180507100040_eux373-B38 article-title: Safety of flecainide publication-title: Drug Saf doi: 10.2165/11599950-000000000-00000 – volume: 3 start-page: 527 year: 1985 ident: key 20180507100040_eux373-B62 article-title: Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes publication-title: Cardiol Clin doi: 10.1016/S0733-8651(18)30650-7 – volume: 16 start-page: 1655 year: 2014 ident: key 20180507100040_eux373-B202 article-title: Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force publication-title: Europace doi: 10.1093/europace/euu208 – volume-title: Oxford Handbook of Drugs in Cardiology year: 2010 ident: key 20180507100040_eux373-B29 doi: 10.1093/med/9780199557462.001.0001 – volume: 4 start-page: 1250 year: 2007 ident: key 20180507100040_eux373-B181 article-title: A practical guide for clinicians who treat patients with amiodarone: 2007 publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2007.07.020 – volume: 8 start-page: 746 year: 2006 ident: key 20180507100040_eux373-B203 article-title: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com publication-title: Europace doi: 10.1093/europace/eul108 – volume: 7 start-page: 237 year: 2014 ident: key 20180507100040_eux373-B104 article-title: Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.113.000805 – volume: 126 start-page: 2302 year: 2012 ident: key 20180507100040_eux373-B114 article-title: Premature atrial contractions in the general population: frequency and risk factors publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.112300 – volume: 16 start-page: 2637 year: 2015 ident: key 20180507100040_eux373-B195 article-title: Advances in the pharmacologic treatment of ventricular arrhythmias publication-title: Expert Opin Pharmacother doi: 10.1517/14656566.2015.1100170 – volume: 36 start-page: 1 year: 2000 ident: key 20180507100040_eux373-B124 article-title: A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation publication-title: Ann Emerg Med doi: 10.1067/mem.2000.107655 – volume: 14 start-page: iii year: 2010 ident: key 20180507100040_eux373-B134 article-title: Systematic review and cost-effectiveness evaluation of ‘pill-in-the-pocket’ strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy publication-title: Health Technol Assess – volume: 95 start-page: 219 year: 2004 ident: key 20180507100040_eux373-B45 article-title: Female preponderance in ibutilide-induced torsade de pointes publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2003.04.034 – volume: 4 start-page: 11 year: 2011 ident: key 20180507100040_eux373-B237 article-title: Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.110.955393 – volume: 10 start-page: 647 year: 2008 ident: key 20180507100040_eux373-B21 article-title: Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches publication-title: Europace doi: 10.1093/europace/eun130 – volume: 49 start-page: 569 year: 2005 ident: key 20180507100040_eux373-B85 article-title: Amiodarone-induced acute lung toxicity in an ICU setting publication-title: Acta Anaesthesiol Scand doi: 10.1111/j.1399-6576.2005.00606.x – volume: 81 start-page: 1450 year: 1998 ident: key 20180507100040_eux373-B125 article-title: Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/S0002-9149(98)00223-9 – year: 2011 ident: key 20180507100040_eux373-B27 – volume: 45 start-page: S1 year: 2005 ident: key 20180507100040_eux373-B60 article-title: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients publication-title: Am J Kidney Dis – volume: 94 start-page: 545 year: 2004 ident: key 20180507100040_eux373-B210 article-title: Prevention of primary ventricular fibrillation in acute myocardial infarction with prophylactic lidocaine publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2004.05.014 – start-page: 127 volume-title: Atrial Fibrillation Therapy year: 2014 ident: key 20180507100040_eux373-B5 doi: 10.1007/978-1-4471-5475-4_6 – volume: 132 start-page: 300 year: 2011 ident: key 20180507100040_eux373-B20 article-title: Novel pharmacological targets for the rhythm control management of atrial fibrillation publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2011.08.002 – volume: 15 start-page: 1389 year: 2013 ident: key 20180507100040_eux373-B219 article-title: Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes publication-title: Europace doi: 10.1093/europace/eut272 – volume: 17 start-page: euv309 year: 2015 ident: key 20180507100040_eux373-B32 article-title: Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation publication-title: Europace doi: 10.1093/europace/euv309 – year: 2017 ident: key 20180507100040_eux373-B224 article-title: Long-term flecainide therapy in type 3 long QT syndrome publication-title: Europace – volume: 62 start-page: 415 year: 2002 ident: key 20180507100040_eux373-B90 article-title: Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment publication-title: Drugs doi: 10.2165/00003495-200262030-00001 – volume: 59 start-page: 255 year: 2004 ident: key 20180507100040_eux373-B164 article-title: Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study publication-title: Acta Cardiol doi: 10.2143/AC.59.3.2005179 – volume: 166 start-page: 442 year: 2013 ident: key 20180507100040_eux373-B129 article-title: Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial publication-title: Am Heart J doi: 10.1016/j.ahj.2013.05.015 – volume: 42 start-page: 75 year: 1999 ident: key 20180507100040_eux373-B86 article-title: Antiarrhythmic drug initiation in patients with atrial fibrillation publication-title: Prog Cardiovasc Dis doi: 10.1016/S0033-0620(99)70010-1 – volume: 65 start-page: 345 year: 2010 ident: key 20180507100040_eux373-B199 article-title: Torsade de pointes with short coupling interval publication-title: Acta Cardiol doi: 10.2143/AC.65.3.2050353 – volume: 6 start-page: 695 year: 2014 ident: key 20180507100040_eux373-B241 article-title: Pharmacology and toxicology of Nav1.5-Class 1 anti-arrhythmic drugs publication-title: Card Electrophysiol Clin doi: 10.1016/j.ccep.2014.07.003 – volume: 19 start-page: 465 year: 2017 ident: key 20180507100040_eux373-B115 article-title: European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE) publication-title: Europace doi: 10.1093/europace/euw301 – volume: 33 start-page: 598 year: 1999 ident: key 20180507100040_eux373-B216 article-title: Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(98)00609-3 – volume: 13 start-page: 329 year: 2011 ident: key 20180507100040_eux373-B182 article-title: Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation publication-title: Europace doi: 10.1093/europace/euq450 – volume: 362 start-page: 1363 year: 2010 ident: key 20180507100040_eux373-B189 article-title: Lenient versus strict rate control in patients with atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa1001337 – volume: 24 start-page: 86 ident: key 20180507100040_eux373-B141 article-title: Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2011.01.080096 – volume: 137 start-page: 792 year: 1999 ident: key 20180507100040_eux373-B204 article-title: Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction publication-title: Am Heart J doi: 10.1016/S0002-8703(99)70401-1 – volume: 17 start-page: 1169 year: 2015 ident: key 20180507100040_eux373-B59 article-title: Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society publication-title: Europace doi: 10.1093/europace/euv202 – volume: 358 start-page: 2678 year: 2008 ident: key 20180507100040_eux373-B167 article-title: Increased mortality after dronedarone therapy for severe heart failure publication-title: N Engl J Med doi: 10.1056/NEJMoa0800456 – volume: 166 start-page: 871 year: 2013 ident: key 20180507100040_eux373-B2 article-title: Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation publication-title: Am Heart J doi: 10.1016/j.ahj.2013.08.010 – volume: 21 start-page: 597 year: 2010 ident: key 20180507100040_eux373-B169 article-title: A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2010.01764.x – volume: 15 start-page: 1805 year: 2013 ident: key 20180507100040_eux373-B227 article-title: Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation publication-title: Europace doi: 10.1093/europace/eut160 – volume: 21 start-page: 2470 year: 1998 ident: key 20180507100040_eux373-B91 article-title: Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.1998.tb01203.x – volume: 115 start-page: 316 year: 2015 ident: key 20180507100040_eux373-B1 article-title: Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2014.11.005 – volume: 66 start-page: 232 year: 2015 ident: key 20180507100040_eux373-B112 article-title: Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.05.018 – volume: 16 start-page: 162 year: 2014 ident: key 20180507100040_eux373-B80 article-title: Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines publication-title: Europace doi: 10.1093/europace/eut274 – volume: 356 start-page: 935 year: 2007 ident: key 20180507100040_eux373-B180 article-title: Amiodarone for atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMct065916 – volume: 2 start-page: 341 year: 2010 ident: key 20180507100040_eux373-B28 article-title: Pharmacokinetics/pharmacodynamics of antiarrhythmic drugs publication-title: Card Electrophysiol Clin doi: 10.1016/j.ccep.2010.06.001 – volume: 135 start-page: 739 year: 1998 ident: key 20180507100040_eux373-B70 article-title: A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery publication-title: Am Heart J doi: 10.1016/S0002-8703(98)70031-6 – volume-title: Stockley’s Drug Interactions year: 2016 ident: key 20180507100040_eux373-B31 – volume: 28 start-page: 617 year: 2011 ident: key 20180507100040_eux373-B35 article-title: Is antiarrhythmic treatment in the elderly different? publication-title: Drugs Aging doi: 10.2165/11591680-000000000-00000 – volume: 17 start-page: 12. year: 2016 ident: key 20180507100040_eux373-B244 article-title: Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect—comprehensive overview of clinical trials publication-title: BMC Pharmacol Toxicol doi: 10.1186/s40360-016-0053-1 – volume: 82 start-page: 1932 year: 1990 ident: key 20180507100040_eux373-B170 article-title: Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation publication-title: Circulation doi: 10.1161/01.CIR.82.6.1932 – volume: 467 start-page: 1081 year: 2015 ident: key 20180507100040_eux373-B23 article-title: Kv1.5 blockers preferentially inhibit TASK-1 channels: TASK-1 as a target against atrial fibrillation and obstructive sleep apnea? publication-title: Pflugers Arch - Eur J Physiol doi: 10.1007/s00424-014-1665-1 – volume: 96 start-page: 546 year: 2010 ident: key 20180507100040_eux373-B93 article-title: Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during ‘pill-in-the-pocket’ treatment publication-title: Heart doi: 10.1136/hrt.2009.187963 – volume: 10 start-page: 145 year: 1996 ident: key 20180507100040_eux373-B177 article-title: Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group publication-title: Cardiovasc Drug Ther doi: 10.1007/BF00823592 – volume: 357 start-page: 987 year: 2007 ident: key 20180507100040_eux373-B166 article-title: Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter publication-title: N Engl J Med doi: 10.1056/NEJMoa054686 – volume: 43 start-page: 2354 year: 2015 ident: key 20180507100040_eux373-B69 article-title: Disappointing success of electrical cardioversion for new-onset atrial fibrillation in cardiosurgical ICU patients publication-title: Crit Care Med doi: 10.1097/CCM.0000000000001257 – start-page: 165 volume-title: Electrophysiological Disorders of the Heart year: 2012 ident: key 20180507100040_eux373-B6 doi: 10.1016/B978-1-4377-0285-9.00012-0 – volume: 37 start-page: 123 year: 1992 ident: key 20180507100040_eux373-B159 article-title: Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation publication-title: Cardiologia – start-page: 3 volume-title: Life-Threatening Effects of Antipsychotic Drugs year: 2016 ident: key 20180507100040_eux373-B201 doi: 10.1016/B978-0-12-803376-0.00001-0 – volume: 16 start-page: 308 year: 2014 ident: key 20180507100040_eux373-B131 article-title: A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry publication-title: Europace doi: 10.1093/europace/eut373 – volume: 34 start-page: 1600 year: 2011 ident: key 20180507100040_eux373-B214 article-title: Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.2011.03208.x – volume: 17 start-page: 1747 year: 2015 ident: key 20180507100040_eux373-B11 article-title: Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoame publication-title: Europace doi: 10.1093/europace/euv233 – volume: 15 start-page: 7 year: 2000 ident: key 20180507100040_eux373-B88 article-title: Inpatient versus outpatient antiarrhythmic drug initiation: safety and cost-effectiveness issues publication-title: Curr Opin Cardiol doi: 10.1097/00001573-200001000-00002 – volume: 348 start-page: 1309 year: 2003 ident: key 20180507100040_eux373-B217 article-title: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa030207 – volume: 13 start-page: 161 year: 2011 ident: key 20180507100040_eux373-B39 article-title: Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation publication-title: Europace doi: 10.1093/europace/euq382 – volume: 1 start-page: 238 year: 2015 ident: key 20180507100040_eux373-B238 article-title: Effect of antiarrhythmic drug initiation on readmission after catheter ablation for atrial fibrillation publication-title: JACC Clin Electrophysiol doi: 10.1016/j.jacep.2015.04.016 – volume: 37 start-page: 267 year: 2016 ident: key 20180507100040_eux373-B197 article-title: 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv320 – volume: 92 start-page: 941 year: 2003 ident: key 20180507100040_eux373-B42 article-title: Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/S0002-9149(03)00974-3 – volume: 9 start-page: 829 year: 2014 ident: key 20180507100040_eux373-B254 article-title: Amiodarone-related thyroid dysfunction publication-title: Intern Emerg Med doi: 10.1007/s11739-014-1140-1 – volume: 34 start-page: 89 year: 2013 ident: key 20180507100040_eux373-B98 article-title: Drug-induced arrhythmia: pharmacogenomic prescribing? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs351 – volume: 9 start-page: iv37. year: 2007 ident: key 20180507100040_eux373-B87 article-title: Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias publication-title: Europace doi: 10.1093/europace/eum169 – volume: 133 start-page: e506 year: 2016 ident: key 20180507100040_eux373-B116 article-title: 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia publication-title: Circulation – volume: 24 start-page: 561 year: 2010 ident: key 20180507100040_eux373-B231 article-title: Achieving low defibrillation thresholds at implant: pharmacological influences, RV coil polarity and position, SVC coil usage and positioning, pulse width settings, and the azygous vein publication-title: Fundam Clin Pharmacol doi: 10.1111/j.1472-8206.2010.00848.x – volume: 14 start-page: 804 year: 2012 ident: key 20180507100040_eux373-B142 article-title: Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial publication-title: Europace doi: 10.1093/europace/eur416 – volume: 77 start-page: 392 year: 1988 ident: key 20180507100040_eux373-B246 article-title: Treatment of torsade de pointes with magnesium sulfate publication-title: Circulation doi: 10.1161/01.CIR.77.2.392 – volume: 55 start-page: 428 year: 2010 ident: key 20180507100040_eux373-B16 article-title: Concept of the vulnerable parameter: the Sicilian Gambit revisited publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e3181bfaddc – volume: 35 start-page: 2733 year: 2014 ident: key 20180507100040_eux373-B58 article-title: 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu284 – volume: 6 start-page: 7 year: 2009 ident: key 20180507100040_eux373-B108 article-title: The conundrum of ventricular arrhythmia and cardiomyopathy: which abnormality came first? publication-title: Curr Heart Fail Rep doi: 10.1007/s11897-009-0003-y – volume: 13 start-page: 308 year: 2011 ident: key 20180507100040_eux373-B17 article-title: Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention publication-title: Europace doi: 10.1093/europace/eur002 – volume: 11 start-page: 736 year: 2000 ident: key 20180507100040_eux373-B233 article-title: Effect of chronic amiodarone therapy on defibrillation energy requirements in humans publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2000.tb00043.x – volume: 13 start-page: 1 year: 2015 ident: key 20180507100040_eux373-B33 article-title: Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms publication-title: Nat Rev Cardiol – volume: 298 start-page: 1157 year: 1978 ident: key 20180507100040_eux373-B100 article-title: Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome publication-title: N Engl J Med doi: 10.1056/NEJM197805252982101 – volume: 136 start-page: 632 year: 1998 ident: key 20180507100040_eux373-B123 article-title: Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators publication-title: Am Heart J doi: 10.1016/S0002-8703(98)70010-9 – volume: 88 start-page: 640 year: 2001 ident: key 20180507100040_eux373-B161 article-title: Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/S0002-9149(01)01806-9 – volume: 3 start-page: CD005049 year: 2015 ident: key 20180507100040_eux373-B53 article-title: Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation publication-title: Cochrane Database Syst Rev – volume: 8 start-page: e80853 year: 2013 ident: key 20180507100040_eux373-B113 article-title: Long-term outcome of healthy participants with atrial premature complex: a 15-year follow-up of the NIPPON DATA 90 cohort publication-title: PLoS One doi: 10.1371/journal.pone.0080853 – volume: 140 start-page: 1036 year: 1980 ident: key 20180507100040_eux373-B247 article-title: Overdrive pacing in quinidine syncope and other long QT-interval syndromes publication-title: Arch Intern Med doi: 10.1001/archinte.1980.00330190048018 – volume: 9 start-page: 284 year: 1988 ident: key 20180507100040_eux373-B179 article-title: Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study publication-title: Eur Heart J doi: 10.1093/oxfordjournals.eurheartj.a062498 – volume: 8 start-page: 1048 year: 2015 ident: key 20180507100040_eux373-B25 article-title: The HARMONY trial publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.115.002856 – volume: 168 start-page: 915 year: 2013 ident: key 20180507100040_eux373-B206 article-title: Early intravenous beta-blockers in patients with acute coronary syndrome—a meta-analysis of randomized trials publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.10.050 – volume: 21 Suppl B start-page: 45B year: 2005 ident: key 20180507100040_eux373-B67 article-title: Atrial fibrillation following cardiac surgery publication-title: Can J Cardiol – start-page: 67 volume-title: Tresch and Aronow’s Cardiovascular Disease in the Elderly year: 2013 ident: key 20180507100040_eux373-B50 – volume: 97 start-page: 2237 year: 1998 ident: key 20180507100040_eux373-B48 article-title: Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry publication-title: Circulation doi: 10.1161/01.CIR.97.22.2237 – volume: 15 start-page: 36S year: 2010 ident: key 20180507100040_eux373-B4 article-title: Atrial fibrillation-the final frontier publication-title: J Cardiovasc Pharmacol Ther doi: 10.1177/1074248410371947 – volume: 27 start-page: 47 year: 2011 ident: key 20180507100040_eux373-B127 article-title: Canadian Cardiovascular Society Atrial fibrillation guidelines 2010: rate and rhythm management publication-title: Can J Cardiol doi: 10.1016/j.cjca.2010.11.001 – volume: 32 start-page: 3147 year: 2011 ident: key 20180507100040_eux373-B65 article-title: ESC Guidelines on the management of cardiovascular diseases during pregnancy publication-title: Eur Heart J doi: 10.1093/eurheartj/ehr218 – volume: 64 start-page: 2741 year: 2004 ident: key 20180507100040_eux373-B92 article-title: Pharmacological cardioversion of atrial fibrillation: current management and treatment options publication-title: Drugs doi: 10.2165/00003495-200464240-00003 – volume: 64 start-page: 280 year: 1981 ident: key 20180507100040_eux373-B30 article-title: Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia publication-title: Circulation doi: 10.1161/01.CIR.64.2.280 – volume: 68 start-page: 1227 year: 1991 ident: key 20180507100040_eux373-B171 article-title: Efficacy and safety of sotalol in digitalized patients with chronic atrial fibrillation. The Sotalol Study Group publication-title: Am J Cardiol doi: 10.1016/0002-9149(91)90200-5 – volume: 91 start-page: 39D year: 2003 ident: key 20180507100040_eux373-B49 article-title: Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues publication-title: Am J Cardiol doi: 10.1016/S0002-9149(02)03378-7 – volume: 35 start-page: 3356 year: 2014 ident: key 20180507100040_eux373-B187 article-title: Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial) publication-title: Eur Heart J doi: 10.1093/eurheartj/ehu354 – volume: 22 start-page: 1504 year: 2001 ident: key 20180507100040_eux373-B157 article-title: Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol publication-title: Eur Heart J doi: 10.1053/euhj.2000.2546 – volume: 100 start-page: 876 year: 2007 ident: key 20180507100040_eux373-B43 article-title: Risk factors and predictors of torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2007.04.020 – volume: 15 start-page: 478 year: 2013 ident: key 20180507100040_eux373-B185 article-title: Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: the European Heart Rhythm Association survey publication-title: Europace doi: 10.1093/europace/eut063 – volume: 13 start-page: 433 year: 2016 ident: key 20180507100040_eux373-B226 article-title: Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with β1-selective β-blockers in patients with catecholaminergic polymorphic ventricular tachycardia publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2015.09.029 – volume: 12 start-page: 1997 year: 2015 ident: key 20180507100040_eux373-B196 article-title: Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: an International VT Ablation Center Collaborative Group Study publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2015.05.036 – volume: 37 start-page: ehv320 year: 2015 ident: key 20180507100040_eux373-B212 article-title: 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation publication-title: Eur Heart J – volume: 42 start-page: 1493 year: 2003 ident: key 20180507100040_eux373-B117 article-title: ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias–executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2003.08.013 – volume: 9 start-page: 988 year: 1998 ident: key 20180507100040_eux373-B55 article-title: Dispersion of ventricular repolarization in left ventricular hypertrophy: influence of afterload and dofetilide publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.1998.tb00140.x – volume: 84 start-page: 1512 year: 2013 ident: key 20180507100040_eux373-B205 article-title: Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest publication-title: Resuscitation doi: 10.1016/j.resuscitation.2013.05.022 – volume: 15 start-page: 1070 year: 2013 ident: key 20180507100040_eux373-B61 article-title: 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) publication-title: Europace doi: 10.1093/europace/eut206 – volume: 21 start-page: 2465 year: 1998 ident: key 20180507100040_eux373-B119 article-title: Oral loading with propafenone: a placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.1998.tb01202.x – volume: 84 start-page: 1831 year: 1991 ident: key 20180507100040_eux373-B14 article-title: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology publication-title: Circulation doi: 10.1161/01.CIR.84.4.1831 – volume: 104 start-page: 671 year: 2009 ident: key 20180507100040_eux373-B139 article-title: Meta-analysis of ablation of atrial flutter and supraventricular tachycardia publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2009.04.040 – volume: 21 start-page: 893 year: 2010 ident: key 20180507100040_eux373-B223 article-title: Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management publication-title: J Cardiovasc Electrophysiol doi: 10.1111/j.1540-8167.2010.01737.x – volume: 39 start-page: 78 year: 2011 ident: key 20180507100040_eux373-B211 article-title: Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181fd6ad7 – year: 1994 ident: key 20180507100040_eux373-B13 – volume: 25 start-page: 1612 year: 2002 ident: key 20180507100040_eux373-B248 article-title: What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers publication-title: Pacing Clin Electrophysiol doi: 10.1046/j.1460-9592.2002.01612.x – volume: 8 start-page: 935 year: 2006 ident: key 20180507100040_eux373-B190 article-title: Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies publication-title: Europace doi: 10.1093/europace/eul106 – volume: 33 start-page: 2569 year: 2012 ident: key 20180507100040_eux373-B207 article-title: ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs215 – volume: 7 start-page: 865 year: 2010 ident: key 20180507100040_eux373-B107 article-title: Relationship between burden of premature ventricular complexes and left ventricular function publication-title: Heart Rhythm doi: 10.1016/j.hrthm.2010.03.036 – volume: 36 start-page: 108 year: 1967 ident: key 20180507100040_eux373-B251 article-title: The electrophysiological properties of diphenylhydantoin sodium as compared to procaine amide in the normal and digitalis-intoxicated heart publication-title: Circulation doi: 10.1161/01.CIR.36.1.108 – volume: 120 start-page: 1036 year: 2009 ident: key 20180507100040_eux373-B236 article-title: Antiarrhythmics after ablation of atrial fibrillation (5A Study) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.839639 – volume: 34 start-page: 496 year: 2012 ident: key 20180507100040_eux373-B36 article-title: Impact of interferences including metabolite crossreactivity on therapeutic drug monitoring results publication-title: Ther Drug Monit doi: 10.1097/FTD.0b013e318261c2c9 – volume: 5 start-page: 175 year: 2013 ident: key 20180507100040_eux373-B242 article-title: Mechanisms of drug-induced proarrhythmia in clinical practice publication-title: World J Cardiol doi: 10.4330/wjc.v5.i6.175 – volume: 106 start-page: 848 year: 1983 ident: key 20180507100040_eux373-B84 article-title: Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia publication-title: Am Heart J doi: 10.1016/0002-8703(83)90007-8 – volume: 33 start-page: 1787 year: 2012 ident: key 20180507100040_eux373-B192 article-title: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart publication-title: Eur Heart J doi: 10.1093/eurheartj/ehs104 – volume: 7 start-page: 29 year: 2015 ident: key 20180507100040_eux373-B243 article-title: Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers publication-title: Clin Pharmacol – volume: 324 start-page: 781 year: 1991 ident: key 20180507100040_eux373-B109 article-title: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial publication-title: N Engl J Med doi: 10.1056/NEJM199103213241201 – volume: 168 start-page: 3287 year: 2013 ident: key 20180507100040_eux373-B140 article-title: 1:1 atrial-flutter. Prevalence and clinical characteristics publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2013.04.047 – volume: 14 start-page: 1385 year: 2012 ident: key 20180507100040_eux373-B130 article-title: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association publication-title: Europace doi: 10.1093/europace/eus305 – volume: 14 start-page: 294 year: 2012 ident: key 20180507100040_eux373-B103 article-title: Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia publication-title: Europace doi: 10.1093/europace/eus009 – volume: 36 start-page: 93 year: 2013 ident: key 20180507100040_eux373-B40 article-title: Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation publication-title: Drug Saf doi: 10.1007/s40264-012-0012-8 – volume: 30 start-page: S112 year: 2007 ident: key 20180507100040_eux373-B234 article-title: Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation publication-title: Pacing Clin Electrophysiol doi: 10.1111/j.1540-8159.2007.00618.x – volume: 127 start-page: 299 year: 2008 ident: key 20180507100040_eux373-B253 article-title: Safety considerations in the pharmacological management of atrial fibrillation publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2007.11.006 – volume: 67 start-page: 407 year: 2012 ident: key 20180507100040_eux373-B235 article-title: Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation publication-title: Acta Cardiol doi: 10.1080/AC.67.4.2170681 – volume: 32 start-page: 7 year: 2014 ident: key 20180507100040_eux373-B239 article-title: Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillation publication-title: Cardiovasc Ther doi: 10.1111/1755-5922.12052 – volume: 26 start-page: 897 year: 2017 ident: key 20180507100040_eux373-B22 article-title: Investigational antiarrhythmic agents: promising drugs in early clinical development publication-title: Expert Opin Investig Drugs doi: 10.1080/13543784.2017.1353601 – volume: 9 start-page: 71 year: 2013 ident: key 20180507100040_eux373-B19 article-title: New directions in antiarrhythmic drug therapy for atrial fibrillation publication-title: Future Cardiol doi: 10.2217/fca.12.78 – volume: 360 start-page: 668 year: 2009 ident: key 20180507100040_eux373-B41 article-title: Effect of dronedarone on cardiovascular events in atrial fibrillation publication-title: N Engl J Med doi: 10.1056/NEJMoa0803778 – volume: 14 start-page: 175 year: 2012 ident: key 20180507100040_eux373-B225 article-title: Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments publication-title: Europace doi: 10.1093/europace/eur277 – volume: 114 start-page: 1483 year: 2014 ident: key 20180507100040_eux373-B26 article-title: Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression publication-title: Circ Res doi: 10.1161/CIRCRESAHA.114.302226 – volume: 165 start-page: 489 year: 2013 ident: key 20180507100040_eux373-B34 article-title: The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development publication-title: Am Heart J doi: 10.1016/j.ahj.2013.01.011 – volume: 121 start-page: 1904 year: 2010 ident: key 20180507100040_eux373-B111 article-title: Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.874982 – volume: 388 start-page: 818 year: 2016 ident: key 20180507100040_eux373-B191 article-title: Rate control in atrial fibrillation publication-title: Lancet doi: 10.1016/S0140-6736(16)31258-2 – volume: 94 start-page: 2535 year: 1996 ident: key 20180507100040_eux373-B44 article-title: Sex difference in risk of torsade de pointes with d,l-sotalol publication-title: Circulation doi: 10.1161/01.CIR.94.10.2535 – volume: 24 start-page: 1481 year: 2003 ident: key 20180507100040_eux373-B168 article-title: Dronedarone for prevention of atrial fibrillation: a dose-ranging study publication-title: Eur Heart J doi: 10.1016/S0195-668X(03)00321-X – volume: 84 start-page: 270 year: 1999 ident: key 20180507100040_eux373-B173 article-title: Maintenance of sinus rhythm with oral d, l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)00275-1 – volume: 106 start-page: 807 year: 1987 ident: key 20180507100040_eux373-B249 article-title: Life-threatening flecainide toxicity. A pharmacodynamic approach publication-title: Ann Intern Med doi: 10.7326/0003-4819-106-6-807 – volume: 99 start-page: 2268 year: 1999 ident: key 20180507100040_eux373-B209 article-title: Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators publication-title: Circulation doi: 10.1161/01.CIR.99.17.2268 – volume: 12 start-page: 1360 year: 2010 ident: key 20180507100040_eux373-B188 article-title: Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) publication-title: Europace doi: 10.1093/europace/euq350 – volume: 64 start-page: 1352 year: 2014 ident: key 20180507100040_eux373-B222 article-title: Efficacy of different beta-blockers in the treatment of long QT syndrome publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2014.05.068 – volume: 1 start-page: CD003611 year: 2013 ident: key 20180507100040_eux373-B71 article-title: Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery publication-title: Cochrane Database Syst Rev – volume: 380 start-page: 238 year: 2012 ident: key 20180507100040_eux373-B158 article-title: Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial publication-title: Lancet (Lond, Engl) doi: 10.1016/S0140-6736(12)60570-4 – volume: 16 start-page: 174 year: 2014 ident: key 20180507100040_eux373-B183 article-title: Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial publication-title: Europace doi: 10.1093/europace/eut293 – volume: 9 start-page: 1105 year: 2007 ident: key 20180507100040_eux373-B220 article-title: Quinidine: a valuable medication joins the list of ‘endangered species’ publication-title: Europace doi: 10.1093/europace/eum181 – volume: 13 start-page: 610 year: 2011 ident: key 20180507100040_eux373-B18 article-title: Upstream therapies for management f atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention publication-title: Europace doi: 10.1093/europace/eur023 – volume: 18 start-page: 881 year: 2016 ident: key 20180507100040_eux373-B106 article-title: Asymptomatic ventricular premature depolarizations are not necessarily benign publication-title: Europace doi: 10.1093/europace/euv112 – volume: 31 start-page: 588 year: 1998 ident: key 20180507100040_eux373-B132 article-title: Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(97)00534-2 – volume: 81 start-page: 995 year: 1998 ident: key 20180507100040_eux373-B144 article-title: Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation publication-title: Am J Cardiol doi: 10.1016/S0002-9149(98)00078-2 – volume: 69 start-page: 1569 year: 2012 ident: key 20180507100040_eux373-B10 article-title: Cost-benefit and cost-savings analyses of antiarrhythmic medication monitoring publication-title: Am J Health Syst Pharm doi: 10.2146/ajhp110270 – volume: 116 start-page: 1845 year: 2015 ident: key 20180507100040_eux373-B47 article-title: Influence of Gender on the Tolerability, Safety, and Efficacy of Quinidine Used for Treatment of Supraventricular and Ventricular Arrhythmias publication-title: Am J Cardiol doi: 10.1016/j.amjcard.2015.09.042 – volume: 337 start-page: 1785 year: 1997 ident: key 20180507100040_eux373-B72 article-title: Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery publication-title: N Engl J Med doi: 10.1056/NEJM199712183372501 – volume: 25 start-page: 51 year: 1995 ident: key 20180507100040_eux373-B153 article-title: A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation publication-title: G Ital Cardiol – volume: 321 start-page: 406 year: 1989 ident: key 20180507100040_eux373-B3 article-title: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJM198908103210629 – volume: 15 start-page: 317 year: 2013 ident: key 20180507100040_eux373-B215 article-title: Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation publication-title: Europace doi: 10.1093/europace/eus380 – volume: 25 start-page: 144 year: 2004 ident: key 20180507100040_eux373-B135 article-title: A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation publication-title: Eur Heart J doi: 10.1016/j.ehj.2003.10.020 – volume: 66 start-page: 1714 year: 2015 ident: key 20180507100040_eux373-B110 article-title: Arrhythmia-induced cardiomyopathies mechanisms, recognition, and management publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2015.08.038 – volume: 8 start-page: 767 year: 2012 ident: key 20180507100040_eux373-B99 article-title: The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure publication-title: Expert Opin Drug Metab Toxicol doi: 10.1517/17425255.2012.685157 – volume: 82 start-page: 1927 year: 2006 ident: key 20180507100040_eux373-B75 article-title: Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis publication-title: Ann Thorac Surg doi: 10.1016/j.athoracsur.2006.06.032 – volume: 130 start-page: 2071 year: 2014 ident: key 20180507100040_eux373-B126 article-title: 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society publication-title: Circulation doi: 10.1161/CIR.0000000000000040 – volume: 2 start-page: 652 year: 2009 ident: key 20180507100040_eux373-B79 article-title: Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.109.870204 – volume: 151 start-page: 863.e1 year: 2006 ident: key 20180507100040_eux373-B149 article-title: A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned publication-title: Am Heart J doi: 10.1016/j.ahj.2005.09.009 – volume: 129 start-page: 468 year: 2016 ident: key 20180507100040_eux373-B133 article-title: Practical management guide for clinicians who treat patients with amiodarone publication-title: Am J Med doi: 10.1016/j.amjmed.2015.08.039 – volume: 19 start-page: 261 year: 2012 ident: key 20180507100040_eux373-B213 article-title: Statin therapy significantly reduces risk of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator publication-title: Am J Ther doi: 10.1097/MJT.0b013e3181f94c38 – volume: 41 start-page: 255 year: 2003 ident: key 20180507100040_eux373-B120 article-title: Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis publication-title: J Am Coll Cardiol doi: 10.1016/S0735-1097(02)02705-5 – volume: 89 start-page: 206 year: 1994 ident: key 20180507100040_eux373-B198 article-title: Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias publication-title: Circulation doi: 10.1161/01.CIR.89.1.206 – volume: 7 start-page: 961 year: 2014 ident: key 20180507100040_eux373-B63 article-title: Contemporary management of arrhythmias during pregnancy publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.114.001517 – reference: 29722802 - Europace. 2018 May 1;20(5):738 |
| SSID | ssj0007295 |
| Score | 2.5783484 |
| SecondaryResourceType | review_article |
| SourceID | swepub proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 731 |
| SubjectTerms | Anti-Arrhythmia Agents - pharmacology Arrhythmias, Cardiac - classification Arrhythmias, Cardiac - diagnosis Arrhythmias, Cardiac - drug therapy Clinical Decision-Making - methods Consensus Drug Monitoring - methods Drug-Related Side Effects and Adverse Reactions - prevention & control Humans Medication Therapy Management - standards |
| Title | Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/29438514 https://www.proquest.com/docview/2002214050 http://kipublications.ki.se/Default.aspx?queryparsed=id:138288029 |
| Volume | 20 |
| WOSCitedRecordID | wos000432254000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1532-2092 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007295 issn: 1099-5129 databaseCode: TOX dateStart: 19990101 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF7aghAXxKsQHtUgIZSoNbVjO7a5RaEQDpQoKVJulr27biuKU8Vxafkp_FpmX45NGqkcuFjWZr07zsznnZmdnSHkTYBaCGc8tRLme5aX-MyKMpRlJwtT32XMpZkti00Eh4fhdBqNNjZ_m7MwF2dBnoeXl9H5f2U1tiGzxdHZf2B3NSg24D0yHa_IdrzeiPH9HEE7n59cLU5E3Dubl8eFVR2ALAu1X1A1MF1kZ_eHrEulDj9TEWOdF2Wxy2a0lPEC1TmUyn8_xH9usTuWE9XZLJTWg-G4LxwOYqrqARMhKo-EiTBYmf5J9J4MRGftuNcOMhxo0AyWHS3TbEvR4DmbzQutQiNlDYLMZDj8cDzB4eVXsDhNLB2HuLZ7f6Qe0KHSdY_pyhus0KbOs8lxPk8GI-Noqe99JJRfW0il5pT5oNzSn6wKXyrdA_9ljcv0dNZwQveP-c9E7R7VyoWjpMlqXbp4mnbsOOEyjFKvRSJ5qtDH6otV166B0q-tPIFaTFdWRJUtjOvXk7eXrqoec02icZUtN_6Odzz2RO623ia53Q38SIRLHn2dVloOGmW-jCTQRJq0WZG7bybbV1M1Nb4VM-6vHL1Srzt6QO5rgwz6CkgPyQbPH5G7X3TIyeNbF008QRNPgHgC5B1UDQZPoPD0HhKo0AQGTSDQBCgrYMABUhpBSSPU0ARtgaWOnKTqrOUQZhkskYQ9J4MOaBSBRBHgAE1JhTqK9sBgCNIrSU-DDDNNGwHR2YM6etZ0lNhRxDaQs0rxCj0aOdAWuOk8Id8-HhwNhpYu1mJRz-suLMaTLPV61LET30vT1KE0YI6fcNelaNUEIXVCFmRpgEoD5U43w0XCDXsus-0kcbnnbpOtfJbzZwSihKHRyqnDuOvxnp2iCcr9wAls3otQZWiRd0agYqorGYiCOmexiqhxYyOBsZLAFmlXD5yrJD7ru742EhrjQit2T5Ocz8pC1Ovtdh20b-0WeapEtxqsG3kumq5ei7zVCDK_rAHV85t2fEHuLb8NL8nWYl7yV-QOvVicFvMdshlMwx0JzD8zEnTf |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiarrhythmic+drugs-clinical+use+and+clinical+decision+making%3A+a+consensus+document+from+the+European+Heart+Rhythm+Association+%28EHRA%29+and+European+Society+of+Cardiology+%28ESC%29+Working+Group+on+Cardiovascular+Pharmacology%2C+endorsed+by+the+Heart+Rhythm+Society+%28HRS%29%2C+Asia-Pacific+Heart+Rhythm+Society+%28APHRS%29+and+International+Society+of+Cardiovascular+Pharmacotherapy+%28ISCP%29&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Dan%2C+G-A&rft.au=Martinez-Rubio%2C+A&rft.au=Agewall%2C+S&rft.au=Boriani%2C+G&rft.date=2018-05-01&rft.issn=1099-5129&rft.volume=20&rft.issue=5&rft.spage=731&rft_id=info:doi/10.1093%2Feuropace%2Feux373&rft.externalDocID=oai_swepub_ki_se_490516 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon |